Tomato Consumption and Health: Emerging Benefits

American Journal of Lifestyle Medicine

Volumn 5, Issue 2, 2011, Pages 182-191

  Burton Freeman, Britt ^a   Reimers, Kristin ^b  

^a ILLINOIS INSTITUTE OF TECHNOLOGY   (United States)

^b ConAgra Foods Inc ^*  (United States)

Author keywords

antioxidant; cancer; vegetable intake; cardiovascular disease; inflammation; lycopene; tomato products; tomatoes

Indexed keywords

EID: 84993710067     PISSN: 15598276     EISSN: None     Source Type: Journal    
DOI: 10.1177/1559827610387488     Document Type: Review

References (102)

1. US Department of Agriculture National Nutrient Database for Standard Reference, Release 22. 2009. http://www.ars.usda.gov/nutrientdata. Accessed October 11, 2010.
2. Rao AV, Agarwal S. Role of lycopene as antioxidant carotenoid in the prevention of chronic diseases: a review. Nutr Res. 1999; 19: 305-323.
3. US Department of Agriculture. Nutrient intakes from food: mean amounts consumed per individual, one day, 2005-2006. 2009; http://www.ars.usda.gov/SP2UserFiles/Place/12355000/pdf/0506/Table_1_NIF_05.pdf
4. Ganji V., Kafai MR Population determinants of serum lycopene concentrations in the United States: data from the Third National Health and Nutrition Examination Survey, 1988-1994. J Nutr. 2005; 135: 567-572.
5. Allen CM, Schwartz SJ, Craft NE, Giovannucci EL, De Groff VL, Clinton SK Changes in plasma and oral mucosal lycopene isomer concentrations in healthy adults consuming standard servings of processed tomato products. Nutr Cancer. 2003; 47: 48-56.
6. Re R., Mishra GD, Thane CW, Bates CJ Tomato consumption and plasma lycopene concentration in people aged 65 y and over in a British national survey. Eur J Clin Nutr. 2003; 57: 1545-1554.
7. Yuan JM, Ross RK, Gao YT, Qu YH, Chu XD, Yu MC Prediagnostic levels of serum micronutrients in relation to risk of gastric cancer in Shanghai, China. Cancer Epidemiol Biomarkers Prev. 2004; 13(11Pt1):1772-1780.
8. Wakai K., Ando M., Ozasa K., et al. Updated information on risk factors for lung cancer: findings from the JACC Study. J Epidemiol. 2005; 15(Suppl 2):S134-S139.
9. Burney PG, Comstock GW, Morris JS Serologic precursors of cancer: serum micronutrients and the subsequent risk of pancreatic cancer. Am J Clin Nutr. 1989;49: 895-900.
10. Gann PH, Ma J., Giovannucci E., et al. Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis. Cancer Res. 1999; 59: 1225-1230.
11. VanEenwyk J., Davis FG, Bowen PE Dietary and serum carotenoids and cervical intraepithelial neoplasia. Int J Cancer. 1991;48: 34-38.
12. Franceschi S., Bidoli E., La Vecchia C., Talamini R., D-Avanzo B., Negri E. Tomatoes and risk of digestive-tract cancers. Int J Cancer. 1994; 59: 181-184.
13. Helzlsouer KJ, Comstock GW, Morris JS Selenium, lycopene, alpha-tocopherol, beta-carotene, retinol, and subsequent bladder cancer. Cancer Res. 1989; 49: 6144-6148.
14. Polidori MC, Mattioli P., Aldred S., et al. Plasma antioxidant status, immunoglobulin G oxidation and lipid peroxidation in demented patients: relevance to Alzheimer disease and vascular dementia. Dement Geriatr Cogn Disord. 2004; 18: 265-270.
15. Mecocci P., Polidori MC, Cherubini A., et al. Lymphocyte oxidative DNA damage and plasma antioxidants in Alzheimer disease. Arch Neurol. 2002; 59: 794-798.
16. Foy CJ, Passmore AP, Vahidassr MD, Young IS, Lawson JT Plasma chain-breaking antioxidants in Alzheimer-s disease, vascular dementia and Parkinson-s disease. QJM. 1999; 92: 39-45.
17. Rao LG, Mackinnon ES, Josse RG, Murray TM, Strauss A., Rao AV Lycopene consumption decreases oxidative stress and bone resorption markers in postmenopausal women. Osteoporos Int. 2007;18: 109-115.
18. Sesso HD, Buring JE, Norkus EP, Gaziano JM Plasma lycopene, other carotenoids, and retinol and the risk of cardiovascular disease in women. Am J Clin Nutr. 2004; 79: 47-53.
19. Yang Z., Zhang Z., Penniston KL, Binkley N., Tanumihardjo SA Serum carotenoid concentrations in postmenopausal women from the United States with and without osteoporosis. Int J Vitam Nutr Res. 2008; 78: 105-111.
20. Maggio D., Polidori MC, Barabani M., et al. Low levels of carotenoids and retinol in involutional osteoporosis. Bone. 2006; 38: 244-248.
21. Anderson LF, Jacobs DR, Gross MD, Schreiner PA, Williams DO, Lee DH Longitudinal associations between body mass index and serum carotenoids: the CARDIA study. Br J Nutr. 2006; 95: 358-365.
22. De Stefani E., Oreggia F., Boffetta P., Deneo-Pellegrini H., Ronco A., Mendilaharsu M. Tomatoes, tomato-rich foods, lycopene and cancer of the upper aerodigestive tract: a case-control in Uruguay. Oral Oncol. 2000; 36: 47-53.
23. Le Marchand L., Yoshizawa CN, Kolonel LN, Hankin JH, Goodman MT Vegetable consumption and lung cancer risk: a population-based case-control study in Hawaii. J Natl Cancer Inst. 1989; 81: 1158-1164.
24. Mucci LA, Tamimi R., Lagiou P., et al. Are dietary influences on the risk of prostate cancer mediated through the insulin-like growth factor system? BJU Int. 2001; 87: 814-820.
25. Jian L., Du CJ, Lee AH, Binns CW Do dietary lycopene and other carotenoids protect against prostate cancer ? Int J Cancer. 2005; 113: 1010-1014.
26. Chen L., Stacewicz-Sapuntzakis M., Duncan C., et al. Oxidative DNA damage in prostate cancer patients consuming tomato sauce-based entrees as a whole-food intervention. J Natl Cancer Inst. 2001; 93: 1872-1879.
27. Walfisch S., Walfisch Y., Kirilov E., et al. Tomato lycopene extract supplementation decreases insulin-like growth factor-I levels in colon cancer patients. Eur J Cancer Prev. 2007;16: 298-303.
28. Giovannucci E., Rimm EB, Liu Y., Stampfer MJ, Willett WC A prospective study of tomato products, lycopene, and prostate cancer risk. J Natl Cancer Inst. 2002; 94: 391-398.
29. Bowen P., Chen L., Stacewicz-Sapuntzakis M., et al. Tomato sauce supplementation and prostate cancer: lycopene accumulation and modulation of biomarkers of carcinogenesis. Exp Biol Med (Maywood). 2002; 227: 886-893.
30. Kim HS, Bowen P., Chen L., et al. Effects of tomato sauce consumption on apoptotic cell death in prostate benign hyperplasia and carcinoma. Nutr Cancer. 2003; 47: 40-47.
31. Bub A., Barth SW, Watzl B., Briviba K., Rechkemmer G. Paraoxonase 1 Q192R (PON1-192) polymorphism is associated with reduced lipid peroxidation in healthy young men on a low-carotenoid diet supplemented with tomato juice. Br J Nutr. 2005; 93: 291-297.
32. Paran E., Novack V., Engelhard YN, Hazan-Halevy I. The effects of natural antioxidants from tomato extract in treated but uncontrolled hypertensive patients. Cardiovasc Drugs Ther. 2009; 23: 145-151.
33. Hadley CW, Clinton SK, Schwartz SJ The consumption of processed tomato products enhances plasma lycopene concentrations in association with a reduced lipoprotein sensitivity to oxidative damage. J Nutr. 2003; 133: 727-732.
34. Jacob K., Periago MJ, Bohm V., Berruezo GR Influence of lycopene and vitamin C from tomato juice on biomarkers of oxidative stress and inflammation. Br J Nutr. 2008; 99: 137-146.
35. Upritchard JE, Sutherland WH, Mann JI Effect of supplementation with tomato juice, vitamin E, and vitamin C on LDL oxidation and products of inflammatory activity in type 2 diabetes. Diabetes Care. 2000; 23: 733-738.
36. Stahl W., Heinrich U., Aust O., Tronnier H., Sies H. Lycopene-rich products and dietary photoprotection. Photochem Photobiol Sci. 2006; 5: 238-242.
37. Stahl W., Heinrich U., Wiseman S., Eichler O., Sies H., Tronnier H. Dietary tomato paste protects against ultraviolet light-induced erythema in humans. J Nutr. 2001; 131: 1449-1451.
38. Edge R., Truscott T. Why lycopene is beneficial against chronic disease: the molecular mechanisms. In: Rao AV, ed. Tomatoes, Lycopene and Human Health Preventing Chronic Diseases. Stranraer, Scotland: Caledonian Science Press; 2006: 77-89.
39. Britton G. Structure and properties of carotenoids in relation to function. FASEB J. 1995; 9: 1551-1558.
40. Rao AV, Rao LG Carotenoids and human health. Pharmacol Res. 2007; 55: 207-216.
41. Di Mascio P., Kaiser S., Sies H. Lycopene as the most efficient biological carotenoid singlet oxygen quencher. Arch Biochem Biophys. 1989; 274: 532-538.
42. Khachik F., Carvallo L., Bernstein P., Muir G., Zhao K., Katz N. Chemistry, distribution and metabolism of tomato carotenoids and their impact on human health. Exp Biol Med (Maywood). 2002; 227: 845-851.
43. Boileau AC, Merchen NR, Wasson K., Atkinson CA, Erdman JW Jr. Cis-lycopene is more bioavailable than trans-lycopene in vitro and in vivo in lymph-cannulated ferrets. J Nutr. 1999; 129: 1176-1181.
44. Unlu NZ, Bohn T., Francis DM, Nagaraja HN, Clinton SK, Schwartz SJ Lycopene from heat-induced cis-isomer-rich tomato sauce is more bioavailable than from all-trans-rich tomato sauce in human subjects. Br J Nutr. 2007; 98: 140-146.
45. Olmedilla B., Granado F., Southon S., et al. A European multicentre, placebo-controlled supplementation study with alpha-tocopherol, carotene-rich palm oil, lutein or lycopene: analysis of serum responses. Clin Sci (Lond). 2002; 102: 447-456.
46. Heber D., Lu QY Overview of mechanisms of action of lycopene. Exp Biol Med (Maywood). 2002; 227: 920-923.
47. Clark PE, Hall MC, Borden LS Jr, et al. Phase I-II prospective dose-escalating trial of lycopene in patients with biochemical relapse of prostate cancer after definitive local therapy. Urology. 2006; 67: 1257-1261.
48. Voskuil DW, Vrieling A., Korse CM, et al. Effects of lycopene on the insulin-like growth factor (IGF) system in premenopausal breast cancer survivors and women at high familial breast cancer risk. Nutr Cancer. 2008; 60: 342-353.
49. Vrieling A., Voskuil DW, Bonfrer JM, et al. Lycopene supplementation elevates circulating insulin-like growth factor binding protein-1 and -2 concentrations in persons at greater risk of colorectal cancer. Am J Clin Nutr. 2007; 86: 1456-1462.
50. Kucuk O., Sarkar FH, Djuric Z., et al. Effects of lycopene supplementation in patients with localized prostate cancer. Exp Biol Med (Maywood). 2002; 227: 881-885.
51. Kristal AR, Arnold KB, Schenk JM, et al. Dietary patterns, supplement use, and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial. Am J Epidemiol. 2008; 167: 925-934.
52. Kucuk O., Sarkar FH, Sakr W., et al. Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy. Cancer Epidemiol Biomarkers Prev. 2001; 10: 861-868.
53. Bunker CH, McDonald AC, Evans RW, de la Rosa N., Boumosleh JM, Patrick AL A randomized trial of lycopene supplementation in Tobago men with high prostate cancer risk. Nutr Cancer. 2007;57: 130-137.
54. Vaishampayan U., Hussain M., Banerjee M., et al. Lycopene and soy isoflavones in the treatment of prostate cancer. Nutr Cancer. 2007; 59: 1-7.
55. Schwarz S., Obermuller-Jevic UC, Hellmis E., Koch W., Jacobi G., Biesalski HK Lycopene inhibits disease progression in patients with benign prostate hyperplasia. J Nutr. 2008; 138: 49-53.
56. Giovannucci E., Ascherio A., Rimm EB, Stampfer MJ, Colditz GA, Willett WC Intake of carotenoids and retinol in relation to risk of prostate cancer. J Natl Cancer Inst. 1995; 87: 1767-1776.
57. Giovannucci E., Liu Y., Platz EA, Stampfer MJ, Willett WC Risk factors for prostate cancer incidence and progression in the health professionals follow-up study. Int J Cancer. 2007; 121: 1571-1578.
58. Chan JM, Holick CN, Leitzmann MF, et al. Diet after diagnosis and the risk of prostate cancer progression, recurrence, and death (United States). Cancer Causes Control. 2006; 17: 199-208.
59. Grainger EM, Schwartz SJ, Wang S., et al. A combination of tomato and soy products for men with recurring prostate cancer and rising prostate specific antigen. Nutr Cancer. 2008; 60: 145-154.
60. Engelhard YN, Gazer B., Paran E. Natural antioxidants from tomato extract reduce blood pressure in patients with grade-1 hypertension: a double-blind, placebo-controlled pilot study. Am Heart J. 2006; 151: 100.
61. Ried K., Frank OR, Stocks NP Dark chocolate or tomato extract for prehypertension: a randomised controlled trial. BMC Complement Altern Med. 2009; 9: 22.
62. Rao AV, Agarwal S. Bioavailability and in vivo antioxidant properties of lycopene from tomato products and their possible role in the prevention of cancer. Nutr Cancer. 1998; 31: 199-203.
63. Hininger IA, Meyer-Wenger A., Moser U., et al. No significant effects of lutein, lycopene or beta-carotene supplementation on biological markers of oxidative stress and LDL oxidizability in healthy adult subjects. J Am Coll Nutr. 2001; 20: 232-238.
64. Bose KS, Agrawal BK Effect of long-term supplementation of tomatoes (cooked) on levels of antioxidant enzymes, lipid peroxidation rate, lipid profile and glycated haemoglobin in Type 2 diabetes mellitus. West Indian Med J. 2006; 55: 274-278.
65. Porrini M., Riso P. Lymphocyte lycopene concentration and DNA protection from oxidative damage is increased in women after a short period of tomato consumption. J Nutr. 2000; 130: 189-192.
66. Porrini M., Riso P., Oriani G. Spinach and tomato consumption increases lymphocyte DNA resistance to oxidative stress but this is not related to cell carotenoid concentrations. Eur J Nutr. 2002; 41: 95-100.
67. Visioli A., Riso P., Grande S., Galli C., Porrini M. Protective activity of tomato products on in vivo markers of lipid oxidation. Eur J Nutr. 2003; 42: 201-206.
68. Kavanaugh CJ, Trumbo PR, Ellwood KC The U.S. Food and Drug Administration-s evidence-based review for qualified health claims: tomatoes, lycopene, and cancer. J Natl Cancer Inst. 2007; 99: 1074-1085.
69. Burton-Freeman B. Summary of research- tomatoes. 2010; http://www.tomatowellness.com/report/. Accessed January 15, 2010.
70. Edinger MS, Koff WJ Effect of the consumption of tomato paste on plasma prostate-specific antigen levels in patients with benign prostate hyperplasia. Braz J Med Biol Res. 2006; 39: 1115-1119.
71. Briviba K., Schnabele K., Rechkemmer G., Bub A. Supplementation of a diet low in carotenoids with tomato or carrot juice does not affect lipid peroxidation in plasma and feces of healthy men. J Nutr. 2004; 134: 1081-1083.
72. Steinberg D. Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem. 1997; 272: 20963-20966.
73. Watzl B., Bub A., Briviba K., Rechkemmer G. Supplementation of a low-carotenoid diet with tomato or carrot juice modulates immune functions in healthy men. Ann Nutr Metab. 2003; 47: 255-261.
74. Blum A., Monir M., Khazim K., Peleg A., Blum N. Tomato-rich (Mediterranean) diet does not modify inflammatory markers. Clin Invest Med. 2007; 30: E70-E74.
75. Bose KS, Agrawal BK Effect of lycopene from tomatoes (cooked) on plasma antioxidant enzymes, lipid peroxidation rate and lipid profile in grade-I hypertension. Ann Nutr Metab. 2007; 51: 477-481.
76. O-Kennedy N., Crosbie L., van Lieshout M., Broom JI, Webb DJ, Duttaroy AK Effects of antiplatelet components of tomato extract on platelet function in vitro and ex vivo: a time-course cannulation study in healthy humans. Am J Clin Nutr. 2006;84: 570-579.
77. O-Kennedy N., Crosbie L., Whelan S., et al. Effects of tomato extract on platelet function: a double-blinded crossover study in healthy humans. Am J Clin Nutr. 2006; 84: 561-569.
78. Stahl W., Sies H. Carotenoids and protection against solar UV radiation. Skin Pharmacol Appl Skin Physiol. 2002; 15: 291-296.
79. Wattanapenpaiboon N., Lukito W., Wahlqvist ML, Strauss BJ Dietary carotenoid intake as a predictor of bone mineral density. Asia Pac J Clin Nutr. 2003; 12: 467-473.
80. Sahni S., Hannan MT, Blumberg J., Cupples LA, Kiel DP, Tucker KL Protective effect of total carotenoid and lycopene intake on the risk of hip fracture: a 17-year follow-up from the Framingham Osteoporosis Study. J Bone Miner Res. 2009; 24: 1086-1094.
81. Sahni S., Hannan MT, Blumberg J., Cupples LA, Kiel DP, Tucker KL Inverse association of carotenoid intakes with 4-y change in bone mineral density in elderly men and women: the Framingham Osteoporosis Study. Am J Clin Nutr. 2009; 89: 416-424.
82. Rinaldi P., Polidori MC, Metastasio A., et al. Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer-s disease. Neurobiol Aging. 2003; 24: 915-919.
83. Polidori MC, Mecocci P. Plasma susceptibility to free radical-induced antioxidant consumption and lipid peroxidation is increased in very old subjects with Alzheimer disease. J Alzheimers Dis. 2002; 4: 517-522.
84. Nguyen M., Francis D., Schwartz S. Thermal isomerisation susceptibility of carotenoids in different tomato varieties. J Sci Food Agric. 2001; 81: 910-917.
85. Shi J., Le Maguer M., Bryan M. Lycopene from tomatoes. In: Shi J, Mazza G, Le Maguer M, eds. Functional Foods: Biochemical and Processing Aspects. Vol. 2. Boca Raton, FL: CRC Press; 2002: 135-167.
86. Clinton SK, Emenhiser C., Schwartz SJ, et al. Cis-trans lycopene isomers, carotenoids, and retinol in the human prostate. Cancer Epidemiol Biomarkers Prev. 1996; 5: 823-833.
87. Erdman JW Jr. How do nutritional and hormonal status modify the bioavailability, uptake, and distribution of different isomers of lycopene? J Nutr. 2005; 135: 2046S-2047S.
88. Gartner C., Stahl W., Sies H. Lycopene is more bioavailable from tomato paste than from fresh tomatoes. Am J Clin Nutr. 1997; 66: 116-122.
89. Schierle J., Bretzel W., Buhler I., et al. Content and isomeric ratio of lycopene in food and human blood plasma. Food Chem. 1997; 59: 459-465.
90. Stahl W., Sies H. Uptake of lycopene and its geometrical isomers is greater from heat-processed than from unprocessed tomato juice in humans. J Nutr. 1992; 122: 2161-2166.
91. Ishida BK, Roberts JS, Chapman MH, Burri BJ Processing tangerine tomatoes: effects on lycopene-isomer concentrations and profile. J Food Sci. 2007; 72: C307-C312.
92. Agarwal A., Shen H., Agarwal S., Rao AV Lycopene content of tomato products: its stability, bioavailability and in vivo antioxidant properties. J Med Food. 2001;4: 9-15.
93. van het Hof KH, Gartner C., West CE, Tijburg LB Potential of vegetable processing to increase the delivery of carotenoids to man. Int J Vitam Nutr Res. 1998; 68: 366-370.
94. Dietary Guidelines for Americans. 6th ed. Washington, DC: US Government Printing Office; 2005.
95. Code of Federal Regulations: Food and Drugs. Washington, DC: US Government Printing Office; 2008: 125-151. 96. Usual dietary intakes. 2009. http://riskfactor.cancer.gov/diet/usualintakes. Accessed October 11, 2010.
96. Casagrande SS, Wang Y., Anderson C., Gary TL Have Americans increased their fruit and vegetable intake? The trends between 1988 and 2002. Am J Prev Med. 2007; 32: 257-263.
97. Lucier G., Biing-Hwan L., Allshouse J., Scott Kantor L. Factors affecting tomato consumption in the United States. Vegetables Specialties. 2000;November:26-32. http://www.ers.usda.gov/Briefing/Vegetables/vegpdf/TomatoConsumption.pdf. Accessed March 23, 2010.
98. years of eating in America. 2010. Food availability data, 1909-2008. http://www.ers.usda.gov/multimedia/FoodAvailability/FoodAvailabilityFinal.swf. Accessed March 23, 2010.
99. Dietary Guidelines Advisory Committee. Report of the Dietary Guidelines Advisory Committee on the Dietary Guidelines for Americans, 2010. 2010; http://www.cnpp.usda.gov/Publications/DietaryGuidelines/2010/DGAC/Report/E-Appendix-E-3FoodPatterns.pdf. Accessed November 1, 2010.
100. Dietary Guidelines Advisory Committee. Report of the Dietary Guidelines Advisory Committee. 2005. http://www.health.gov/dietaryguidelines/dga2005/report/HTML/C_Methodology.htm. Accessed March 23, 2010.
101. Panel on Dietary Intakes for Electrolytes and Water. Potassium. Dietary Reference Intakes for Water, Potassium, Sodium, Chloride, and Sulfate. Washington, DC: National Academies Press; 2005: 186-268.
102. Food and Nutrition Board. Water and electrolytes. Recommended Dietary Allowances. Washington, DC: National Academies Press; 1989: 247-261.